BioCentury
ARTICLE | Company News

Novartis grants Oncology Venture an option to an undisclosed small molecule to treat cancer

July 28, 2017 8:22 PM UTC

Novartis AG (NYSE:NVS; SIX:NOVN) granted Oncology Venture Sweden AB (AktieTorget:OV) an exclusive option to develop and commercialize an undisclosed small molecule kinase inhibitor in development to treat multiple cancers including solid tumors. ...